AI-generated summary
This review summarizes clinical and animal studies linking inflammation in brain circuits to anxiety and depression, and examines whether neuromodulation therapies, including photobiomodulation, reduce neuroinflammation. The authors report that several neuromodulation methods have been reported to attenuate neuroinflammation and reduce pro-inflammatory factors, which may partly explain mood improvement. They suggest inflammatory biomarkers may help guide assessment and treatment choices.
- Who or what was studied
- People with anxiety or depression, including refractory mood disorders, and animal models
- Limits stated in the abstract
- The abstract notes that treatment efficacy varies between individuals and lacks reliable indicators, and it does not report included study counts or quantitative results.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Mood disorders are associated with elevated inflammation, and the reduction of symptoms after multiple treatments is often accompanied by pro-inflammation restoration. A variety of neuromodulation techniques that regulate regional brain activities have been used to treat refractory mood disorders. However, their efficacy varies from person to person and lack reliable indicator. This review summarizes clinical and animal studies on inflammation in neural circuits related to anxiety and depression and the evidence that neuromodulation therapies regulate neuroinflammation in the treatment of neurological diseases. Neuromodulation therapies, including transcranial magnetic stimulation (TMS), transcranial electrical stimulation (TES), electroconvulsive therapy (ECT), photobiomodulation (PBM), transcranial ultrasound stimulation (TUS), deep brain stimulation (DBS), and vagus nerve stimulation (VNS), all have been reported to attenuate neuroinflammation and reduce the release of pro-inflammatory factors, which may be one of the reasons for mood improvement. This review provides a better understanding of the effective mechanism of neuromodulation therapies and indicates that inflammatory biomarkers may serve as a reference for the assessment of pathological conditions and treatment options in anxiety and depression.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Neuromodulation, Neuroinflammation, Depression, Anxiety, Inflammation, Transcranial magnetic stimulation, Photobiomodulation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.